Natural cytotoxicity and antibody-dependent cellular cytotoxicity (ADCC) is not impaired in patients suffering from chronic hepatitis C

被引:35
作者
Düesberg, U
Schneiders, AM
Flieger, D
Inchauspé, G
Sauerbruch, T
Spengler, U
机构
[1] Univ Bonn, Dept Internal Med 1, D-53105 Bonn, Germany
[2] INSERM, Unite 271, Lyon, France
关键词
chronic hepatitis C; natural cytotoxicity; antibody dependent cellular cytotoxicity; long term assay;
D O I
10.1016/S0168-8278(01)00194-5
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: Recent observations suggest that natural killer (NK) cell activity might be impaired in chronic hepatitis C. However, to date antibody-dependent cellular cytotoxicity (ADCC) has not been studied in chronic hepatitis C in detail. Methods: Therefore, we investigated spontaneous and cytokine-induced (interleukin-2 and interferon-gamma) natural cytotoxicity and ADCC in 29 patients suffering from chronic hepatitis C and 19 healthy controls. Cytotoxicity was determined with a flow-cytometric assay, which can also assess monocyte cytotoxicity. As target cells we used the colorectal tumor cell line HT29 and the lymphoma cell line Raji. Results: We found no significant differences with respect to spontaneous cytotoxicity (HCV versus healthy controls (32 vs. 46%) and 17-1A specific ADCC (59 vs. 48%), even if isolated monocytes or NK cells were studied. Preincubation and stimulation of effector cells with cytokines; increased both natural cytotoxicity and ADCC by 20-30%. However, natural cytotoxicity and ADCC after stimulation did not differ between the two groups. Conclusions: Our data obtained with a long-term cytotoxicity assay do not reveal impaired cytolytic capacity of the innate immune system in chronic hepatitis C, even when isolated monocytes and NK cells were studied as effector cells. (C) 2001 European Association for the Study of the Liver. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:650 / 657
页数:8
相关论文
共 29 条
[21]   ANTIBODY-DEPENDENT ANTITUMOR CYTO-TOXICITY BY HUMAN-MONOCYTES CULTURED WITH RECOMBINANT MACROPHAGE COLONY-STIMULATING FACTOR - INDUCTION OF EFFICIENT ANTIBODY-MEDIATED ANTITUMOR CYTO-TOXICITY NOT DETECTED BY ISOTOPE RELEASE ASSAYS [J].
MUNN, DH ;
CHEUNG, NKV .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (02) :511-526
[22]   Decrease in CD3-CD8 and Vγ9/Vδ2 TCR+ T cell count and low perforin expression is associated with an impairment of natural killer cell activity in hepatitis C virus (HCV) infection.: The enhancing effects of interferonα 2b treatment [J].
Pár, G ;
Pàr, A ;
Rukavina, D ;
Horánvi, M ;
Szekeres-Bartho, J ;
Hegedüs, G ;
Paál, M ;
Mózsik, G .
JOURNAL OF HEPATOLOGY, 2000, 32 :93-93
[23]  
Rehermann B, 2000, CURR TOP MICROBIOL, V242, P299
[24]   Cellular immune response to the hepatitis C virus [J].
Rehermann, B .
JOURNAL OF VIRAL HEPATITIS, 1999, 6 :31-35
[25]  
ROOZEMOND RC, 1987, J IMMUNOL, V139, P1739
[26]   BIOLOGY OF NATURAL-KILLER CELLS [J].
TRINCHIERI, G .
ADVANCES IN IMMUNOLOGY, 1989, 47 :187-376
[27]   RESPONSE OF RESTING HUMAN PERIPHERAL-BLOOD NATURAL-KILLER CELLS TO INTERLEUKIN-2 [J].
TRINCHIERI, G ;
MATSUMOTOKOBAYASHI, M ;
CLARK, SC ;
SEEHRA, J ;
LONDON, L ;
PERUSSIA, B .
JOURNAL OF EXPERIMENTAL MEDICINE, 1984, 160 (04) :1147-1169
[28]   RISK-FACTORS FOR HEPATOCELLULAR-CARCINOMA AMONG PATIENTS WITH CHRONIC LIVER-DISEASE [J].
TSUKUMA, H ;
HIYAMA, T ;
TANAKA, S ;
NAKAO, M ;
YABUUCHI, T ;
KITAMURA, T ;
NAKANISHI, K ;
FUJIMOTO, I ;
INOUE, A ;
YAMAZAKI, H ;
KAWASHIMA, T .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (25) :1797-1801
[29]  
XIAO CW, 1991, CANCER DETECT PREV, V15, P211